• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Becker Muscular Dystrophy

Becker Muscular Dystrophy - 32 Studies Found

Completed : CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers
:
  • Duchenne Muscular Dystrophy
  • Becker Muscul
    : 2012-02-23
    : Drug: CRD007
Active, not recruiting : Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis
:
  • Becker Muscular Dystrophy
  • Sporadic Inclusion Body Myositis

  • : 2012-01-23
    : Biological: rAAV1.CMV.huFollistatin344

Completed : Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
:
  • Becker Muscular Dystrophy
  • Limb-Girdle Muscular Dystrophy Type 2
    : 2014-06-11
Completed : Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy
: Becker Muscular Dystrophy
: 2014-03-25
:
  • Dietary Supplement: Sodium Nitrate
  • Dietary

Completed : Functional Muscle Ischemia With Tadalafil Treatment in Becker Muscular Dystrophy
: Becker Muscular Dystrophy
: 2014-09-23
:
  • Drug: Tadalafil
  • Other: Placebo

Completed : High-dose Prednisone in Duchenne Muscular Dystrophy
: Duchenne Muscular Dystrophy
: 2005-05-12
: Drug: Prednisone Prednisone and dummy preparations for this study will be obtained from Frank's Pharmacy
Completed : Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients
: Becker Muscular Dystrophy
: 2011-05-04
:
  • Drug: Sildenafil 20 mg in gela

Completed : An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy
: Duchenne Muscular Dystrophy
: 2016-09-14
: Biological: PF-06252616 Either 5mg/kg, 20mg/kg or 40mg/kg will be assigned to a subject based on their m
Completed : A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
: Duchenne Muscular Dystrophy
: 2014-11-04
:
  • Biological: PF-06252616 PF-062

Withdrawn : Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2
: Duchenne Muscular Dystrophy
: 2015-12-23
:
  • Biological: rAAVrh74.MCK.GALGT2

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.